Hub providers can be the source of the best real-world evidence
A Conversation with Mark Hansan, CareMetx
2020 Patient Support / Hub Services Report
Dramatic growth tracks the flood of new specialty pharmaceuticals entering the market
Merging data for managing pharma commercialization
Multi-faceted software platforms seek to unify salesforce automation with commercial and compliance activity
Gimme my data
Ownership of supply chain data is becoming contentious
The 2018 Pharma Cold Chain: more data leads to less risk
Pharma supply chain managers now have options for dealing with cryogenic to room-temperature ranges
Blockchain to the rescue?
A Conversation with Louis Roy, Optel Group
Traceability will lead to better pharma supply chains and ultimately, a better social environment
Traceability end-of-year update
FDA plods along; industry builds out barcode installations, and IT experts pay closer attention to blockchain technology
MDM’s growing role in running healthcare businesses
The pharma industry has a growing number of dependencies on reliable master data
It’s time for an industry guideline on patient support services
Pharmaceutical traceability stumbles ahead
FDA’s delay will not alter industry goals
Blockchain: the technology to make DSCSA work after 2023?
Industry experts are grappling with the eventual requirement to provide accurate supply-chain traceability
The sales rep study I’d like to see
A Conversation with John Chiminski, Catalent
Taking on the breadth of challenges in contract development and manufacturing, globally
Thermal blankets find a growing cold chain role
Management of controlled room-temperature shipments generates rising demand
2017 Hub Services report
Rising tide of specialties lifts most providers’ businesses
Affordable Care Act repeal: which side are you on?
Hey, what’s this supply chain stuff?
The medical crisis that didn’t happen
Pharma traceability: year in review
The tempo of project work is accelerating to meet deadlines in 2017 and beyond
A conversation with Gerry Gleeson, Walgreens Specialty Pharmacy
Enough already with REMS abuse in generic drug development
3PLs set specialty pharmaceutical markets in motion
Managing the physical movement of specialty drugs calls for dedicated services
A conversation with Terry Hisey, Deloitte
Serialization’s interface between the plant floor, the enterprise and the world
Dispense As Written
Specialty pharmacy dynamics
The SP channel continues to grow, with manufacturers looking for more control over access